Cevdet Furkan Köşker

Dr. Cevdet Furkan Köşker

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2026 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
GTGurhan Taskin
Gurhan Taskin
MEMete Erdemir
Mete Erdemir
ÖÖÖ. Faruk Özdemir
Ö. Faruk Özdemir
MYMahmut YILMAZ
Mahmut YILMAZ
CKCevdet Furkan Köşker
Cevdet Furkan Köşker
LYLevent Yamanel
Levent Yamanel
Continuous renal replacement therapy (CRRT) provides vital organ support in acute kidney injury but is associated with the inadvertent extracorporeal clear

22 July 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
CKCevdet Furkan Köşker
Cevdet Furkan Köşker
GTGurhan Taskin
Gurhan Taskin
MEMete Erdemir
Mete Erdemir
ŞBŞerife Bozdaş
Şerife Bozdaş
RGRamazan GÜMRAL
Ramazan GÜMRAL
LYLevent Yamanel
Levent Yamanel
Candida auris is an emerging multidrug-resistant yeast associated with healthcare-associated transmission and severe outcomes in intensive care settings. C

15 August 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
HTHasan Burak Toprak
Hasan Burak Toprak
MEMete Erdemir
Mete Erdemir
EBElif Bilgiç
Elif Bilgiç
CKCevdet Furkan Köşker
Cevdet Furkan Köşker
ŞBŞerife Bozdaş
Şerife Bozdaş
LYLevent Yamanel
Levent Yamanel
Background and Objectives: The C-reactive protein-to-albumin ratio (CAR) is associated with mortality and poor outcome after acute ischemic stroke, but the association is not the same as added clinical usefulness. We evaluated whether admission CAR and follow-up CAR provide prognostic information beyond a prespecified parsimonious clinical reference model comprising age, neurological severity, and admission glucose in critically ill patients with acute ischemic stroke. Materials and Methods: In this single-center retrospective cohort of 146 adults with acute ischemic stroke managed in intensive care, CAR was calculated from C-reactive protein and serum albumin at emergency department admission and at the first intensive care laboratory assessment. The primary outcome was 90-day all-cause mortality. A clinical reference model (age, admission National Institutes of Health Stroke Scale [NIHSS] score, admission glucose) was compared with the same model augmented by log-transformed CAR using the area under the receiver operating characteristic curve (AUC), the DeLong test, likelihood-ratio (LR) testing, and bootstrap optimism-corrected performance. Results: Ninety-day mortality occurred in 32 of 146 patients (21.9%) (full cohort; primary complete-case analysis: 141 patients with 31 events). In the primary complete-case analysis (n = 141; 31 events), admission CAR was not independently associated with mortality (odds ratio per 1-SD log CAR 1.46, 95% confidence interval 0.91–2.33; p = 0.115). Adding admission CAR changed the AUC from 0.768 (0.676–0.860) to 0.783 (0.693–0.874) (ΔAUC +0.016, 95% confidence interval −0.024 to +0.055; DeLong p = 0.444; LR p = 0.113), with optimism-corrected point estimates of 0.750 and 0.754. Follow-up CAR did not add value (LR p = 0.159), and change in CAR did not improve discrimination (ΔAUC +0.001; LR p = 0.945); because intensive care sampling times were not standardized, these analyses assess incremental prognostic information rather than CAR kinetics. Admission CAR was not associated with poor 90-day functional outcome (odds ratio 1.09, 95% confidence interval 0.83–1.44; p = 0.530). Conclusions: Admission CAR did not demonstrate measurable incremental prognostic value beyond the prespecified clinical reference model, and follow-up CAR and change-based analyses did not improve prediction, although non-standardized sampling times mean that serial CAR kinetics were not fully evaluated. The confidence intervals remain compatible with both no effect and a positive effect of uncertain clinical relevance, but the observed improvement was insufficient to support CAR as a stand-alone or routinely additive prognostic marker in this setting.

28 May 2025 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
CKCevdet Furkan Köşker
Cevdet Furkan Köşker
RAReşit Emre Alparğan
Reşit Emre Alparğan
MCMuhammed Ali Coşkuner
Muhammed Ali Coşkuner
GKGökhan Köker
Gökhan Köker
BBBilgin Bahadır Başgöz
Bilgin Bahadır Başgöz
This study aimed to investigate the relationship between short-term blood pressure variability (BPV) and anticholinergic burden (ACB) in adults with hypertension. This study included 238 hypertensive patients aged 50 and older who underwent ambulatory blood pressure monitoring. The medications used by the patients were recorded, and the ACB of each medication was calculated using the ACB Scale. The BPV was assessed based on 24-hour ambulatory blood pressure measurements using three methods: standard deviation (SD), coefficient of variation of the standard deviation (SD-CoV), and weighted standard deviation (wSD), with evaluations conducted for both day-time and night-time periods. A total of 139 patients (58.40%) had no ACB score, 64 (26.89%) had an ACB score of 1, and 35 (14.71%) had an ACB score of 2 or higher. ACB scores were significantly higher among patients with heart disease, and ACB tended to increase with age. However, no statistically significant relationship was found between ACB and mean blood pressure, nocturnal blood pressure dips, or any parameters of short-term BPV including Sd, SD-CoV and wSD. No significant association was found between ACB and short-term BPV. To the best of our knowledge, this is the first study to investigate this relationship, which may inspire further research.